See the DrugPatentWatch profile for vascepa
There is no definitive scientific evidence to suggest that garlic pills interfere with the efficacy of Vascepa (icosapent ethyl), a medication used to reduce the risk of cardiovascular events in adults with elevated triglyceride levels. However, it is important to note that garlic and Vascepa are both substances that can affect blood clotting and cholesterol levels, so it is advisable to consult with a healthcare provider before combining the two.
Garlic has been studied for its potential cholesterol-lowering effects, but the results have been mixed. Some studies have found that garlic can lower total cholesterol and LDL ("bad") cholesterol levels, while others have found no significant effect. Additionally, garlic has been shown to have antiplatelet effects, which means it can inhibit blood clotting.
Vascepa, on the other hand, is a prescription medication that is specifically approved to reduce the risk of cardiovascular events in adults with elevated triglyceride levels. It works by reducing the production of triglycerides in the body and increasing the breakdown of existing triglycerides.
While there is no direct evidence that garlic pills interfere with the efficacy of Vascepa, it is possible that the antiplatelet effects of garlic could potentially interact with the blood-thinning effects of Vascepa. This could potentially increase the risk of bleeding, although this is purely speculative and there is no evidence to support this hypothesis.
In summary, while there is no evidence to suggest that garlic pills interfere with the efficacy of Vascepa, it is important to consult with a healthcare provider before combining the two, as both substances can affect blood clotting and cholesterol levels.
Sources:
* <
https://www.drugpatentwatch.com/drugs/vascepa>
* <
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164832/>
* <
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803551/>
* <
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913102/>
* <
https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-prescribers-about-vascepa-icosapent-ethyl-capsules-375-mg>